Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 8, 2010Journal of Antimicrobial Chemotherapy

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

View Full Paper
Ask AI
Bookmark
Share

Authors

EHElizabeth B. HirschUniversity of MinnesotaVTVincent H. TamUniversity of Houston

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hirsch et al. (2010) studied this question.

synapsesocial.com/papers/6a6fb01ff44fa9f079dd290bhttps://doi.org/10.1093/jac/dkq108
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>2002 · 145 citations
  2. 2Genetic Structures at the Origin of Acquisition of the β-Lactamase <i>bla</i> <sub>KPC</sub> Gene2008 · 545 citations
  3. 3Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom2008 · 145 citations
  4. 4Treatment of Recurrent Urosepsis with Tigecycline: a Pharmacological Perspective2008 · 34 citations
  5. 5Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system2009 · 156 citations